Anti SERPINA3 pAb (ATL-HPA002560 w/enhanced validation)

Atlas Antibodies

Catalog No.: ATL-HPA002560-25

Protein Description: serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
Gene Name: SERPINA3
Alternative Gene Name: AACT, ACT, alpha-1-antichymotrypsin
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000079012: 60%, ENSRNOG00000010478: 59%
Entrez Gene ID: 12
Uniprot ID: P01011
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications

• Application: WB, IHC
• Reactivity: Human
• Clonality: Polyclonal
• Host: Rabbit
• Immunogen: QDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQEGAPHR
• Gene Sequence: QDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQEGAPHR
• Gene ID - Mouse: ENSMUSG00000079012
• Gene ID - Rat: ENSRNOG00000010478
• Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Citations for Anti SERPINA3 pAb (ATL-HPA002560 w/enhanced validation) – 3 Found

Häggmark, Anna; Byström, Sanna; Ayoglu, Burcu; Qundos, Ulrika; Uhlén, Mathias; Khademi, Mohsen; Olsson, Tomas; Schwenk, Jochen M; Nilsson, Peter. Antibody-based profiling of cerebrospinal fluid within multiple sclerosis. Proteomics. 2013;13(15):2256-67. 

Bannon, Michael J; Johnson, Magen M; Michelhaugh, Sharon K; Hartley, Zachary J; Halter, Steven D; David, James A; Kapatos, Gregory; Schmidt, Carl J. A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype. Neuropsychopharmacology : Official Publication Of The American College Of Neuropsychopharmacology. 2014;39(9):2191-9. 

31801975. ACNP 58(th) Annual Meeting: Poster Session II. Neuropsychopharmacology : Official Publication Of The American College Of Neuropsychopharmacology. 2019;44(Suppl 1):230-384.